Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, et al. The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts. Clin Infect Dis. 2014;58:214–24.
Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vacc Immunother. 2018;14:1311–22.
Sim JJL, Lim CC. Influenza vaccination in systemic lupus erythematosus: efficacy, effectiveness, safety, utilization, and barriers. Am J Med. 2022;135:286–96.
Article CAS PubMed Google Scholar
Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventative strategies. Lupus. 2013;22:1286–94.
Article CAS PubMed Google Scholar
Arnaud L, Tektonidou MG. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford). 2020;59:v29–38.
Article CAS PubMed Google Scholar
Chang C-C, Chang Y-S, Chen W-S, Chen Y-H, Chen J-H. Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus: a nationwide cohort study. Sci Rep. 2016;6:37817.
Article CAS PubMed PubMed Central Google Scholar
Hurd A, Beukelman T. Infectious complications in juvenile idiopathic arthritis. Curr Rheumatol Rep. 2013;15:327.
Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfa E, Silva CA, et al. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting. Mod Rheumatol. 2018;28:264–70.
Aygun D, Sahin S, Adrovic A, Barut K, Cokugras H, Camcioglu Y, et al. The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study. Clin Rheumatol. 2019;38:1025–30.
Walters HM, Pan N, Lehman TJA, Adams A, Huang W-T, Sitaras L, et al. A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors. Clin Rheumatol. 2015;34:457–64.
Becker I, Horneff G. Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German biologics in pediatric rheumatology registry. Arthritis Care Res. 2017;69:552–60.
Blumentals WA, Arreglado A, Napalkov P, Toovey S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskel Dis. 2012;13:158.
Joo YB, Kim K-J, Park K-S, Park Y-J. Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization. Sci Rep. 2021;11:4630.
Article CAS PubMed PubMed Central Google Scholar
Marie I, Menard J-F, Hachulla E, Cherin P, Benveniste O, Tiev K, et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum. 2011;41:48–60.
Ge YP, Shu XM, He LR, Wang GC, Lu X. Infection is not rare in patients with idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2022;40:254–9.
Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, et al. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Arthritis Care Res. 2015;67:673–80.
Joo YB, Lim Y-H, Kim K-J, Park K-S, Park Y-J. Association of influenza infection with hospitalization-related systemic lupus erythematosus flares: a time series analysis. Clin Exp Rheumatol. 2021;39:1056–62.
Carvalho LM, de Paula FE, Silvestre RVD, Roberti LR, Arruda E, Mello WA, et al. Prospective surveillance study of acute respiratory infections, influenza-like illnesses and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients. Pediatr Rheumatol. 2013;11:10.
Bax CE, Maddukuri S, Ravishankar A, Pappas-Taffer L, Werth VP. Environmental triggers of dermatomyositis: a narrative review. Ann Transl Med. 2021;9:434.
Article CAS PubMed PubMed Central Google Scholar
Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices – United States, 2023–2024 Influenza Season. MMWR Recomm Rep. 2023;72:1–25.
Article PubMed Central Google Scholar
Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Rheumatol. 2022;74:570–85.
Article PubMed PubMed Central Google Scholar
Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, et al. EULAR/PRES recommendations for vaccination of paeditric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis. 2023;82:35–47.
Article CAS PubMed Google Scholar
Furer V, Rondaan C, Heijstek M, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79:39–52.
Article CAS PubMed Google Scholar
Rubin LG, Levin MJ, Ljungman P, Davies G, Avery R, Tomblyn M, et al. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. Clin Infect Dis. 2014;58:e44–100.
National Center for Health Statistics. Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/fastats/flu.htm. Accessed 25 Jan 2024.
Tuckerman J, Misan S, Salih S, Xavier BJ, Crawford NW, Lynch J, et al. Influenza vaccination: uptake and associations in a cross-sectional study of children with special risk medical conditions. Vaccine. 2018;36:8138–47.
Provost LP, Murray SK. The Health Care Data Guide: Learning from Data for Improvement. 1st ed. San Francisco, CA: Jossey-Bass; 2011.
Fuller A, Hancox J, Vedhara K, Card T, Mallen C, Nguyen Van-Tam JS, et al. Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic. PLoS ONE. 2022;17:e0267769.
Article CAS PubMed PubMed Central Google Scholar
Lawson EF, Trupin L, Yelin EH, Yazdany J. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2015;44:666–71.
Article PubMed PubMed Central Google Scholar
Carlson SJ, Quinn HE, Blyth CC, Chen A, Clark J, Francis JR. Barriers to influenza vaccination of children hospitalized for acute respiratory illness: A cross-sectional survey. J Paediatr Child Health. 2021;57:409–18.
Tuckerman J, Crawford NW, Marshall HS. Disparities in parental awareness of children’s seasonal influenza vaccination recommendations and influencers of vaccination. PLoS ONE. 2020;15:e0230425.
Article CAS PubMed PubMed Central Google Scholar
Figueroa-Parra G, Moreno-Salinas A, Santoyo-Fexas L, Gamboa-Alonso CM, Carrizales-Luna JP, Hernandez-Galarza IJ, et al. Vaccination in rheumatic disease patients: results of a pilot quality improvement program. Reumatologia. 2021;59:362–6.
Article PubMed PubMed Central Google Scholar
Harrison N, Poeppl W, Miksch M, Machold K, Kiener H, Aletaha D, et al. Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases. Vaccine. 2018;36:4875–9.
Chen Y, Chen B, Shen X, Zhou A, Liang Y, Wang Y, et al. A survey of systemic lupus erythematosus patients’ attitudes toward influenza and pneumococcal vaccination in Southwest China. Front Public Health. 2022;10:1018899.
留言 (0)